Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Sr MD General Counsel | March 17, 2026 | March 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date March 17, 2026 · Filed March 23, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 7,192 |
Reported balance
After 2026-03-17 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-03-17 · Sale · Disposed 3,291 · Balance 7,192 F1: This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2025. F2: This amendment is being filed to correct the price per share of the common stock sold on March 17, 2026, which was incorrectly reported on the original Form 4 filed on March 19, 2026 due to a clerical error. All other information in the original Form 4 remains unchanged. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2025.
F2: This amendment is being filed to correct the price per share of the common stock sold on March 17, 2026, which was incorrectly reported on the original Form 4 filed on March 19, 2026 due to a clerical error. All other information in the original Form 4 remains unchanged.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 17, 2026 Filed Mar 19, 2026 13:47 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 3,291 | $333.37 | $1,097,120.67 |
DisclosureSEC source: 0001628280-26-019658 · wk-form4_1773928030.xml · nonDerivative · entry 1 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,192 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2025. Read SEC document |
| March 17, 2026 Filed Mar 23, 2026 13:38 UTC Amendment | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 3,291 | $313.37 | $1,031,300.67 |
DisclosureSEC source: 0001628280-26-020364 · wk-form4a_1774273136.xml · nonDerivative · entry 1 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,192 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2025. F2 · price: This amendment is being filed to correct the price per share of the common stock sold on March 17, 2026, which was incorrectly reported on the original Form 4 filed on March 19, 2026 due to a clerical error. All other information in the original Form 4 remains unchanged. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:24 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 261 | $311.40 | $81,275.40 |
DisclosureSEC source: 0001628280-26-018544 · wk-form4_1773764642.xml · nonDerivative · entry 3 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,483 F3 · shares: Mr. Marcus surrendered shares to the company to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2026. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:24 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,377 | $311.40 | $740,197.80 |
DisclosureSEC source: 0001628280-26-018544 · wk-form4_1773764642.xml · nonDerivative · entry 2 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,744 F2 · shares: Mr. Marcus surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:24 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 5,270 | $311.40 | $1,641,078.00 |
DisclosureSEC source: 0001628280-26-018544 · wk-form4_1773764642.xml · nonDerivative · entry 1 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,121 F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025. Read SEC document |
| September 18, 2025 Filed Sep 18, 2025 23:30 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 392 | $262.00 | $102,704.00 |
DisclosureSEC source: 0001952996-25-000007 · wk-form4_1758238225.xml · nonDerivative · entry 1 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,851 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2025 Read SEC document |
| September 16, 2025 Filed Sep 17, 2025 17:49 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 294 | $259.83 | $76,390.02 |
DisclosureSEC source: 0001952996-25-000005 · wk-form4_1758131342.xml · nonDerivative · entry 4 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,243 F3 · shares: Mr. Marcus surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025. Read SEC document |
| September 16, 2025 Filed Sep 17, 2025 17:49 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 376 | $258.96 | $97,368.96 |
DisclosureSEC source: 0001952996-25-000005 · wk-form4_1758131342.xml · nonDerivative · entry 3 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,537 F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2025. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 17:49 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,464 | $258.83 | $637,757.12 |
DisclosureSEC source: 0001952996-25-000005 · wk-form4_1758131342.xml · nonDerivative · entry 2 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,913 Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 17:49 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 259 | $258.83 | $67,036.97 |
DisclosureSEC source: 0001952996-25-000005 · wk-form4_1758131342.xml · nonDerivative · entry 1 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,449 F1 · shares: Mr. Marcus surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2025. Read SEC document |
| May 20, 2025 Filed May 21, 2025 17:43 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 390 | $277.50 | $108,225.00 |
DisclosureSEC source: 0001156375-25-000130 · wk-form4_1747849427.xml · nonDerivative · entry 1 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,708 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2025. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 16:18 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 269 | $258.68 | $69,584.92 |
DisclosureSEC source: 0001156375-25-000049 · wk-form4_1742314696.xml · nonDerivative · entry 1 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,098 F1 · shares: Mr. Marcus surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2025. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 23:11 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,744 | $218.53 | $599,646.32 |
DisclosureSEC source: 0001156375-24-000175 · wk-form4_1726614664.xml · nonDerivative · entry 2 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,367 Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 23:11 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 271 | $216.99 | $58,804.29 |
DisclosureSEC source: 0001156375-24-000175 · wk-form4_1726614664.xml · nonDerivative · entry 1 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,623 F1 · shares: Mr. Marcus surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 15:24 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 282 | $217.50 | $61,335.00 |
DisclosureSEC source: 0001156375-24-000049 · wk-form4_1710861850.xml · nonDerivative · entry 1 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,894 F1 · shares: Mr. Marcus surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2024. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:06 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,540 | $206.82 | $525,322.80 |
DisclosureSEC source: 0001156375-23-000148 · wk-form4_1695074807.xml · nonDerivative · entry 1 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,176 Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 17:51 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,636 | $182.67 | $481,518.12 |
DisclosureSEC source: 0001156375-23-000036 · wf-form4_167907547167509.xml · nonDerivative · entry 1 Marcus Jonathan L · CIK 0001952996 · Sr MD General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,636 F1 · shares: On March 15, 2023, the reporting person was granted restricted shares, vesting in four equal annual installments on the first four anniversaries of the grant date, subject to the terms and conditions of the CME Group Inc. Omnibus Stock Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.